GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (FRA:AC6) » Definitions » FFO

AlzeCure Pharma AB (FRA:AC6) FFO


View and export this data going back to 2019. Start your Free Trial

What is AlzeCure Pharma AB FFO?

FFO (Funds from operations) only applies to REITs.


AlzeCure Pharma AB Business Description

Traded in Other Exchanges
Address
Halsovagen 7, Huddinge, SWE, SE 141 57
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms NeuroRestore, Alzstatin, and Painless. The company's drug candidates include; ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, ACD679, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.